← All trials
NCT02866136
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2012
- Primary completion
- Feb 1, 2019
- Completion date
- Feb 1, 2027
- First posted
- —
- Last posted
- —
- Enrollment
- 133
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Curie InstituteLead sponsor
- Bocage UniversityOverall official - principal investigator
- Jean Monnet UniversityOverall official - principal investigator
- University of AngersOverall official - principal investigator
- University of LimogesOverall official - principal investigator
- University of Western BrittanyOverall official - principal investigator
- University of GrenobleOverall official - principal investigator
- University of NantesOverall official - principal investigator
- University of ReimsOverall official - principal investigator
- Rouen Normandy UniversityOverall official - principal investigator
- University of RennesOverall official - principal investigator
- University of PoitiersOverall official - principal investigator
- University of Caen-NormandieOverall official - principal investigator
- University of MontpellierOverall official - principal investigator
- University of Nice Sophia AntipolisOverall official - principal investigator
- University of LilleOverall official - principal investigator
- Aix-University of MarseilleOverall official - principal investigator
- University of LorraineOverall official - principal investigator
- François Rabelais UniversityOverall official - principal investigator
- University of StrasbourgOverall official - principal investigator
- Adolphe Rothschild Ophtalmologic FoundationOverall official - principal investigator
- University of Picardie Jules VerneOverall official - principal investigator
- Children Hospital of ToulouseOverall official - principal investigator
- Centre Leon BerardOverall official - principal investigator
- Adolphe Rothschild Ophtalmologic FoundationCollaborator
- University of BordeauxOverall official - principal investigator
- University Clermont AuvergneOverall official - principal investigator
- Curie InstituteStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.